Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood|May 18, 2012
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samplesKeiki Kumano, Shunya Arai, Masataka Hosoi, et al.
Plos One|December 3, 2010
Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditionsYohei Hayashi, Techuan Chan, Masaki Warashina, et al.
Human Gene Therapy|March 17, 2009
Kinetics and effect of integrin expression on human CD34(+) cells during murine leukemia virus-derived retroviral transduction with recombinant fibronectin for stem cell gene therapyYasuomi Horiuchi, Masafumi Onodera, Yoshitaka Miyagawa, et al.
The Journal of Clinical Investigation|August 3, 2013
Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signalingShinji Hirata, Naoya Takayama, Ryoko Jono-Ohnishi, et al.
Molecular Therapy. Methods & Clinical Development|November 17, 2021
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clonesToru Uchiyama, Sirirat Takahashi, Kazuhiko Nakabayashi, et al.
Plos One|October 3, 2013
Profiling of microRNA in human and mouse ES and iPS cells reveals overlapping but distinct microRNA expression patternsSiti Razila Abdul Razak, Kazuko Ueno, Naoya Takayama, et al.
The Journal of Experimental Medicine|November 25, 2010
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cellsNaoya Takayama, Satoshi Nishimura, Sou Nakamura, et al.
Stem Cell Reports|February 28, 2017
An All-Recombinant Protein-Based Culture System Specifically Identifies Hematopoietic Stem Cell Maintenance FactorsAki Ieyasu, Reiko Ishida, Takaharu Kimura, et al.
Scientific Reports|October 28, 2018
Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronateKazuki Taoka, Shunya Arai, Keisuke Kataoka, et al.
Stem Cell Reports|December 28, 2013
Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cellsSho-Ichi Hirose, Naoya Takayama, Sou Nakamura, et al.
Pageof 9